Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy
Standard
Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy. / Schlange, Thomas; Pantel, Klaus.
in: PHARMACOGENOMICS, Jahrgang 17, Nr. 3, 02.2016, S. 183-6.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
Schlange, T & Pantel, K 2016, 'Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy', PHARMACOGENOMICS, Jg. 17, Nr. 3, S. 183-6. https://doi.org/10.2217/pgs.15.163
APA
Schlange, T., & Pantel, K. (2016). Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy. PHARMACOGENOMICS, 17(3), 183-6. https://doi.org/10.2217/pgs.15.163
Vancouver
Schlange T, Pantel K. Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy. PHARMACOGENOMICS. 2016 Feb;17(3):183-6. https://doi.org/10.2217/pgs.15.163
Bibtex
@article{b4042c17bf304e798df1026663e3a478,
title = "Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy",
author = "Thomas Schlange and Klaus Pantel",
year = "2016",
month = feb,
doi = "10.2217/pgs.15.163",
language = "English",
volume = "17",
pages = "183--6",
journal = "PHARMACOGENOMICS",
issn = "1462-2416",
publisher = "Future Medicine Ltd",
number = "3",
}
RIS
TY - JOUR
T1 - Potential of circulating tumor cells as blood-based biomarkers in cancer liquid biopsy
AU - Schlange, Thomas
AU - Pantel, Klaus
PY - 2016/2
Y1 - 2016/2
U2 - 10.2217/pgs.15.163
DO - 10.2217/pgs.15.163
M3 - Other (editorial matter etc.)
C2 - 26799583
VL - 17
SP - 183
EP - 186
JO - PHARMACOGENOMICS
JF - PHARMACOGENOMICS
SN - 1462-2416
IS - 3
ER -
